Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology
21 févr. 2024 09h00 HE | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused...
Alterity.png
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
20 févr. 2024 10h25 HE | ALTERITY THERAPEUTICS LIMITED
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to be Presented from Ongoing ATH434-201 Phase 2...
Parkinson’s Disease
Parkinson’s Disease Patient Identification and Education Will Need to Improve When New Disease Modifying Therapies Are Approved, According to Spherix Global Insights
16 févr. 2024 10h40 HE | Spherix Global Insights
EXTON, PA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Millions of people worldwide are affected by Parkinson’s disease (PD), prompting the need for effective disease-modifying therapies (DMTs) to target this...
Vaccinex logo
Vaccinex, Inc. Announces Reverse Stock Split
15 févr. 2024 08h00 HE | Vaccinex, Inc.
ROCHESTER, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease...
Research Nester Logo.jpg
Endoscopy Devices Market revenue to surpass USD 52 Billion by 2036, says Research Nester
13 févr. 2024 06h30 HE | Research Nester
New York , Feb. 13, 2024 (GLOBE NEWSWIRE) -- The global endoscopy devices market size is projected to grow at a CAGR of over 5% from 2024 to 2036. The market is expected to garner a revenue of USD...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
08 févr. 2024 16h02 HE | Athira Pharma, Inc.
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
MnM_logo_TM_JPG.JPG
Therapeutic Hypothermia Systems Market is Expected to Reach $396 Million | MarketsandMarkets™
07 févr. 2024 07h30 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Therapeutic Hypothermia Systems market in terms of revenue was estimated to be worth $291 million in 2023 and is poised to reach $396 million by 2028,...
Research Nester Logo.jpg
Medical Imaging Market revenue to reach USD 60 Billion by 2033, says Research Nester
07 févr. 2024 06h30 HE | Research Nester
New York , Feb. 07, 2024 (GLOBE NEWSWIRE) -- The global medical imaging market size is projected to grow at a CAGR of over 6% from 2023 to 2033. The market is expected to garner a revenue of USD 60...
Research Nester Logo.jpg
Nuclear Medicine Market revenue to surpass USD 20 Billion by 2033, says Research Nester
07 févr. 2024 05h30 HE | Research Nester
New York, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The global nuclear medicine market size is predicted to expand at ~20% CAGR between 2023 and 2033. The market is projected to garner a revenue of USD 20...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Neurovascular Devices Market Increase to USD 6.2 Billion by 2033 | Remarkable 7.6% CAGR
07 févr. 2024 04h24 HE | Market.Us
New York, Feb. 07, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Neurovascular Devices Market size is forecasted to exceed USD 6.2 Billion by 2033, with a promising CAGR of 7.6% from...